Applied Imaging joins EU-funded cancer study
This article was originally published in Clinica
Applied Imaging has become one of three commercial partners accepted as a collaborator on the DISMAL-project, a European-based, three-year biomarker study on detection and dissemination of tumour cells.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.